Revenio Group Oyj
Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company offers iCare IC100, ST500, and IC200 tonometers; iCare HOME2, a tonometer to measure eye pressure; iCare Probes that are accessories of iCare tonometer for measuring intraocular pre… Read more
Market Cap & Net Worth: Revenio Group Oyj (REVXF)
Revenio Group Oyj (OTCGREY:REVXF) has a market capitalization of $740.91 Million ($740.91 Million) as of March 18, 2026. Listed on the OTCGREY stock exchange, this USA-based company holds position #8731 globally and #4344 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Revenio Group Oyj's stock price $27.85 by its total outstanding shares 26603425 (26.60 Million).
Revenio Group Oyj Market Cap History: 2015 to 2025
Revenio Group Oyj's market capitalization history from 2015 to 2025. Data shows growth from $1.77K to $740.91 Million (292.49% CAGR).
Revenio Group Oyj Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Revenio Group Oyj's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
6.75x
Revenio Group Oyj's market cap is 6.75 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
42.58x
Revenio Group Oyj's market cap is 42.58 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $7.62 Million | $61.07 Million | $13.36 Million | 0.12x | 0.57x |
| 2021 | $1.95 Billion | $78.78 Million | $17.32 Million | 24.74x | 112.53x |
| 2022 | $1.15 Billion | $96.98 Million | $21.75 Million | 11.81x | 52.66x |
| 2023 | $1.15 Billion | $96.58 Million | $19.11 Million | 11.96x | 60.44x |
| 2024 | $754.21 Million | $103.50 Million | $18.50 Million | 7.29x | 40.77x |
| 2025 | $740.91 Million | $109.70 Million | $17.40 Million | 6.75x | 42.58x |
Competitor Companies of REVXF by Market Capitalization
Companies near Revenio Group Oyj in the global market cap rankings as of March 18, 2026.
Key companies related to Revenio Group Oyj by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Revenio Group Oyj Historical Marketcap From 2015 to 2025
Between 2015 and today, Revenio Group Oyj's market cap moved from $1.77K to $ 740.91 Million, with a yearly change of 292.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $740.91 Million | -1.76% |
| 2024 | $754.21 Million | -34.69% |
| 2023 | $1.15 Billion | +0.82% |
| 2022 | $1.15 Billion | -41.24% |
| 2021 | $1.95 Billion | +25464.62% |
| 2020 | $7.62 Million | +429964.15% |
| 2019 | $1.77K | 0.00% |
| 2018 | $1.77K | 0.00% |
| 2017 | $1.77K | 0.00% |
| 2016 | $1.77K | 0.00% |
| 2015 | $1.77K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Revenio Group Oyj was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $740.91 Million USD |
| MoneyControl | $740.91 Million USD |
| MarketWatch | $740.91 Million USD |
| marketcap.company | $740.91 Million USD |
| Reuters | $740.91 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.